Fujifilm Participates in APRC 2026, Reinforcing Leadership
in Medical Innovation and Showcasing AI Technology
Assistant Professor (Special) Dr. Nabphlika Kongpolprom, a member of the APRC 2026 Academic Committee and a member of the Academic Committee of the Thai Society of Thoracic Medicine under the Royal Patronage, revealed the importance of long-term proactive screening to eradicate tuberculosis, stating, “This APRC academic conference is a great opportunity for Thailand to host. The Tuberculosis Control Association and the Thai Society of Thoracic Medicine jointly organized this event, allowing medical personnel to exchange ideas on screening, diagnosis, and new treatment approaches from healthcare professionals in many countries. What I want to emphasize is the development of projects that increase patient access to tuberculosis diagnosis and treatment. Such projects must be continued. I believe that with continuous screening programs, Thailand can eradicate tuberculosis quickly.”
Mr. Takuma Otsuka, Head of Global Marketing and Global Health, Modality Solution Division, Medical Systems Business Division, Fujifilm Corporation, said, “The highlight of Fujifilm's innovations is that they are designed with the patient in mind, providing safe, convenient use and building confidence among medical personnel.” "Our low-dose imaging innovations minimize unnecessary radiation exposure, crucial for large-scale screening and follow-up, such as in factories or community outreach activities, while maintaining sharp and accurate image quality and efficient workflows for faster diagnosis and improved patient care, especially for mobile medical units in remote areas."
Fujifilm's comprehensive medical solutions enable healthcare professionals to bring technology closer to patients, reduce healthcare disparities, and increase access to timely diagnosis and treatment. Fujifilm's AI-powered digital X-ray machines enable faster and more accurate screening of lung cancer and tuberculosis, reducing diagnostic errors and detecting small lesions invisible to the human eye, leading to earlier treatment for patients. Furthermore, the rapid TB-LAM urine test kit allows for rapid and accurate detection of tuberculosis in HIV patients, where chest X-rays and sputum tests may be inaccurate.
This is ideal for use in community health centers and HIV clinics that may lack advanced laboratory facilities and equipment for screening. Fujifilm's bronchoscope further integrates the efficiency of screening with treatment. This technology helps doctors visualize the airways for accurate diagnosis of lung cancer, tuberculosis, and other complex respiratory diseases. It also aids in assessing early lesions by collecting tissue samples, in cases where imaging alone is insufficient. This minimally invasive method allows for timely diagnosis and treatment. Fujifilm is committed to supporting proactive lung screening projects by public health agencies and Thailand's ongoing "End Tuberculosis" campaign through practical medical solutions for mobile units, empowering out-of-hospital services, particularly for proactive screening programs organized by public health agencies
Go To Lead
|
